Target intelligence / Profile preview

Kelch domain-containing protein 2 (KLHDC2)

Target
KLHDC2
Molecular classification
Ubiquitin ligase, E3 ligase
01

Overview

KLHDC2 is a substrate-recognition component of the Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, involved in the degradation of proteins ending with specific C-terminal sequences, such as diglycine (Gly-Gly). It plays a crucial role in the ubiquitin-proteasome pathway, particularly through the recognition of C-end degrons in aberrant or truncated proteins. This information is based on the role of KLHDC2 in protein degradation and its involvement in processes like ubiquitination. KLHDC2 acts as part of the DesCEND pathway, targeting proteins with specific C-terminal motifs for degradation. Its role in cancer, particularly in hepatocellular carcinoma, is reflected in its alternative names.

Other names
HCLP-1LCPHepatocellular carcinoma-associated antigen 33Host cell factor homolog LCPHost cell factor-like protein 1
02

Mechanism of action

Recognition of C-end degrons leading to ubiquitination and degradation of target proteins

03

Biological functions

Ubiquitin-dependent protein catabolic processProtein degradationMaintenance of protein homeostasis
04

Disease associations

Cancer

Beyond the preview

Go deeper on Kelch domain-containing protein 2 (KLHDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch domain-containing protein 2 (KLHDC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call